TOVIMED
Board
1 director, since incorporationDirector
appointed by deed of 12-06-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 19-05-2026
Mandates through the years
1 name, the dashed line is todayBoard
Mandates as a list
- VIZLI Tom Paul Abdullah Li Nassengue
- Director, appointed by deed of 12-06-2023, still in office
Control
This company
TOVIMED
Equity €105,588
Profit €54,927 in 2025
Capital
- Contribution
- €1,500
- Shares
- 15
- Contribution per share
- €100
- Equity per share
- €7,039 in 2025
- Source
- deed of 12-06-2023
Articles of association
deed of 12-06-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 20 April at 18:00
Shareholders
At incorporation
deed of 12-06-2023 ↗
- VIZLI Tom Paul Abdullah Li Nassengue 15 shares (100%) · €1,500 in cash